Navigation Links
TOPICA Announces Participation in BioPartnering North America
Date:1/25/2010

PALO ALTO, Calif., Jan. 25 /PRNewswire/ -- TOPICA Pharmaceuticals today announced that Greg Vontz, president and CEO, will present at BioPartnering North America on Monday, January 25, at 2:45 p.m. Pacific Time at the Westin Bayshore Resort in Vancouver, BC.

During the presentations, Mr. Vontz will provide an overview of TOPICA and its clinical development plans for luliconazole, one of the most potent and broad spectrum topical antifungal agents, for the treatment of onychomycosis (fungal infections of the nail) and tinea pedis (athlete's foot).

About TOPICA Pharmaceuticals

TOPICA is a privately-held specialty pharmaceutical company focused on licensing, developing and commercializing potent topical prescription products to treat the needs of patients with serious nail and skin conditions. Taking advantage of its established trans-pacific network of scientific and industry contacts, TOPICA has in-licensed its lead product candidate, luliconazole, a topical antifungal agent that is already on the market in Japan. TOPICA is developing luliconazole for the treatment of tinea pedis (athlete's foot) and onychomycosis (fungal infections of the nail). For more information, please visit http://www.topicapharma.com.

SOURCE TOPICA Pharmaceuticals

RELATED LINKS
http://www.topicapharma.com

'/>"/>

SOURCE TOPICA Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds
2. Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
3. TOPICA Announces Positive Phase 2 Clinical Results for Luliconazole, a Potent Topical Antifungal
4. Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
5. ProFibrix Initiates Phase II Clinical Trial of its Lead Topical Hemostat Product Fibrocaps(TM)
6. Arcion Therapeutics Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy
7. Fast-Acting, Long-Lasting Topical Relief From Arthritis Pain
8. NovaBay Pharmaceuticals Announces Lead Anti-infective Product Candidate, NVC-422, Shown to be Effective in Treating Topical Fungal Infection
9. ISTA Pharmaceuticals Announces Phase III Results for Once-Daily Topical Xibrom(TM) 0.09%
10. Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream
11. Topical Treatment for Cold Sores Achieves Efficacy of Oral Drugs; Represents Paradigm Shift in the Treatment of Skin Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... LONDON , May 24, 2016 ... erfüllt beide primären Endpunkte ... und Überlegenheit in ‚ausgezeichneter plus guter ... aufsteigenden Colons    ,      (Logo: ... B.V. gab heute neue positive Daten von der ...
(Date:5/24/2016)... N.J. , May 24, 2016 ... oncology drug development company, today provided an update ... dose escalating clinical trial combining GEN-1, the Company,s ... the treatment of newly-diagnosed patients with advanced ovarian ... interval debulking surgery.  GEN-1 is an IL-12 DNA ...
(Date:5/24/2016)... 2016 Open Access Journal ... Elsevier , a world-leading provider of ... announced the launch of Clinical Neurophysiology ... focuses on clinical practice issues in clinical neurophysiology. The ... normal values and didactic reviews. It is an official ...
Breaking Medicine Technology:
(Date:5/24/2016)... , ... (PRWEB) May ... three new members of its Advisory Board. Joining the Grow ... Kusch. “All three of them embody the mission of our organization ... very fortunate to have them as we continue to expand our ...
(Date:5/24/2016)... ... May 24, 2016 , ... A newly released report ... on their access to trusted resources, both in face-to-face interactions and online. In “Heard, ... Color,” researchers concluded that the creative use of mobile digital devices can be an ...
(Date:5/24/2016)... , ... May 24, 2016 , ... ... 2016 increased by 9.3 million people, or 10% over last year, according to ... people covered under group policies was comparatively stable, with a slight decrease in ...
(Date:5/24/2016)... , ... May 24, 2016 , ... Controlling and maintaining ... with the launch of the Aquanta Water Heater Controller , a first-of-its-kind system ... or web-enabled device. As the Nest thermostat does for HVAC systems, Aquanta gives ...
(Date:5/24/2016)... Angeles, California (PRWEB) , ... May 24, 2016 , ... ... $4,000, food, clothing, supplies and other necessities to Eunime Orphanage in Tijuana, Mexico on ... pizza and play games at Peter Piper Pizza. , More than 15 volunteers ...
Breaking Medicine News(10 mins):